ProBioGen AG

ProBioGen is an expert in the development and manufacturing of biopharmaceuticals, viral vectors, and vaccines, powered by proprietary technologies that enhance product quality and features. As a Berlin-based CDMO operating for over 30 years, ProBioGen runs three manufacturing lines, where 300 employees contribute to advancing next-generation therapies and global biotech innovation. The company’s growth strategy focuses on expanding its service value chain through organic growth and strategic opportunities, with a clear mission to enable tomorrow’s biopharmaceuticals.